Additional information
| Active substance | Survodutide |
|---|---|
| Hepatotoxicity | No significant hepatotoxicity reported |
| Lab Test | Monitoring blood glucose levels and HbA1c |
| Also known as | LY3298176 |
| Blood pressure | May reduce blood pressure |
| Trade name | Mounjaro |
| FORM | 1 vial x 10 mg |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F), protect from light |
| Chemical name | Tirzepatide |
| Formula | C225H348N48O68 |
| Substance class | Glucagon-like peptide-1 (GLP-1) receptor agonists |
| Main action | Lowers blood glucose levels |
| Half-life | Approximately 5 days |
| Dosage (medical) | Typically started at 2.5 mg once weekly, can be increased to 5 mg, 10 mg, or 15 mg once weekly depending on response and tolerability |
| Dosage (sports) | Not applicable as it is not used for performance enhancement |
| Effects | Improves glycemic control, promotes weight loss |
| Side effects | Nausea, diarrhea, decreased appetite, vomiting, constipation |
| Use in sports | None, not used for performance enhancement |
| Manufacturer | Dragon Pharma |
Fostimon (Merional) 75 (HMG) IBSA
BIOSYNERGY RECOVERY3 PEPTIDE BLEND LIFETECH LABS
Balkan Pharma Strombafort 10mg 100 Tabletten
Spiriva HandiHaler 18mg Boehringer Ingelheim
Norvacs 5 mg Pfizer
Norditropin 30 IE (10 mg) menschliches Wachstumshormon
Avory Pharma Anavar 10 mg 100 Kapseln
Zimaks 400 Bilim
Zyban Glaxosmithkline
FUCIDIN 500 mg Abdi Ibragim
CLENBOLIC Cooper Pharma 

Reviews
There are no reviews yet.